Literature DB >> 17507157

Application of acidogenic fixed-bed reactor prior to anaerobic membrane bioreactor for sustainable slaughterhouse wastewater treatment.

Ahlem Saddoud1, Sami Sayadi.   

Abstract

High rate anaerobic treatment systems such as anaerobic membrane bioreactors (AMBR) are less popular for slaughterhouse wastewater due to the presence of high fat oil and suspended matters in the effluent. This affects the performance and efficiency of the treatment system. In this work, AMBR has been tried for slaughterhouse wastewater treatment. After the start up period, the reactor was operated with an average organic loading rate (OLR) of 4.37 kg TCODm(-3)d(-1) with gradual increase to an average of 13.27 kg TCODm(-3)d(-1). At stable conditions, the treatment efficiency was high with an average COD and BOD(5) reduction of 93.7 and 93.96%, respectively. However, a reduction in the AMBR performance was shown with the increase of the OLR to 16.32 kg TCODm(-3)d(-1). The removal efficiencies of SCOD and BOD(5) were drastically decreased to below 53.6 and 73.3%, respectively. The decrease of the AMBR performance was due to the accumulation of VFAs. Thus, a new integrated system composed of a FBR for the acidogenesis step followed by the AMBR for methanogenesis step was developed. At high ORL, the integrated system improved the performance of the anaerobic digestion and it successfully overcame the VFA accumulation problem in the AMBR. The anaerobic treatment led to a total removal of all tested pathogens. Thus, the microbiological quality of treated wastewater fits largely with WHO guidelines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507157     DOI: 10.1016/j.jhazmat.2007.04.031

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  1 in total

1.  Treatment of the Supernatant of Anaerobically Digested Organic Fraction of Municipal Solid Waste in a Demo-Scale Mesophilic External Anaerobic Membrane Bioreactor.

Authors:  Antonio Giménez-Lorang; José Ramón Vázquez-Padín; Cecilia Dorado-Barragán; Gloria Sánchez-Santos; Sandra Vila-Armadas; Xavier Flotats-Ripoll
Journal:  Front Bioeng Biotechnol       Date:  2021-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.